The TrumpRx site now lists more than 61 discounted medications from 11 drugmakers, up from about 40 when it launched in February.

Moderate to severe glabellar lines may be effectively and safely treated with YY001, a new recombinant botulinum toxin type A product.

Despite the initiation of a phase 3 confirmatory trial, the FDA remains unsatisfied with the interpretability of phase 2 data for Replimune’s oncolytic immunotherapy.

Circulating tumor HPV DNA levels were linked to clinical risk in patients having surgery for HPV-related oropharyngeal cancer.

Immunocompetent adults younger than 50 years of age experience a substantial HZ burden, with incidence rates comparable to older age groups.

The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.